Skip to main content

Table 3 Resuscitative endovascular balloon occlusion of the aorta (REBOA) procedure data and adverse events

From: Effect of resuscitative endovascular balloon occlusion of the aorta in nontraumatic out-of-hospital cardiac arrest: a multinational, multicenter, randomized, controlled trial

 

Total (n = )

REBOA group (n = )

ED arrival to REBOA inflation interval (s)

  

Insertion depth of REBOA catheter (cm)

  

Amount of NS used for ballooning (cc)

  

Adverse events

 Device-related complications

  

  Malposition

  

   Insertion failure

  

   Insertion site hematoma

  

  Insertion site infection

  

  Balloon rupture

  

  Catheter removal failure

  

 Vascular access-related complications

  

  Femoral artery injury

  

  Lower limb ischemia

  

  Amputation

  

  Aorta injury

  

 Adverse events

  AKI with dialysis

  

  ARDS

  

  Pneumonia

  

  Sepsis/septic shock

  

  Stroke/CVA

  

  Paraplegia

  

  Myocardial infarction

  

  Multiorgan failure

  

  Neurologic deficit secondary to spinal cord ischemia

  

  Ventilator days

  

  Length of ICU stay

  

  Length of hospital stay

  

  In hospital stay

  

  Mortality, hours after admission

  

  Mortality, hospital days

  
  1. ED Emergency department, REBOA Resuscitative endovascular balloon occlusion of aorta, NS Normal saline, AKI Acute kidney injury, ARDS Acute respiratory distress syndrome, CVA Cerebrovascular accident, ICU Intensive care unit